131 related articles for article (PubMed ID: 35841647)
1. The role of catechin in electroporation of pancreatic cancer cells - Effects on pore formation and multidrug resistance proteins.
Michel O; Szlasa W; Baczyńska D; Saczko J; Tarek M; Kulbacka J
Bioelectrochemistry; 2022 Oct; 147():108199. PubMed ID: 35841647
[TBL] [Abstract][Full Text] [Related]
2. The favourable effect of catechin in electrochemotherapy in human pancreatic cancer cells.
Michel O; Przystupski D; Saczko J; Szewczyk A; Niedzielska N; Rossowska J; Kulbacka J
Acta Biochim Pol; 2018; 65(2):173-184. PubMed ID: 29796442
[TBL] [Abstract][Full Text] [Related]
3. New therapeutic strategy: Personalization of pancreatic cancer treatment-irreversible electroporation (IRE), electrochemotherapy (ECT) and calcium electroporation (CaEP) - A pilot preclinical study.
Rudno-Rudzińska J; Kielan W; Guziński M; Płochocki M; Antończyk A; Kulbacka J
Surg Oncol; 2021 Sep; 38():101634. PubMed ID: 34303953
[TBL] [Abstract][Full Text] [Related]
4. Effects of calcium electroporation, electrochemotherapy, and irreversible electroporation on quality of life and progression-free survival in patients with pancreatic cancer: IREC clinical study.
Rudno-Rudzińska J; Kielan W; Guziński M; Kulbacka J
Adv Clin Exp Med; 2021 Jul; 30(7):765-770. PubMed ID: 34313408
[TBL] [Abstract][Full Text] [Related]
5. Electroporation with Cisplatin against Metastatic Pancreatic Cancer:
Michel O; Kulbacka J; Saczko J; Mączyńska J; Błasiak P; Rossowska J; Rzechonek A
Biomed Res Int; 2018; 2018():7364539. PubMed ID: 29750170
[TBL] [Abstract][Full Text] [Related]
6. Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.
Stein U; Lage H; Jordan A; Walther W; Bates SE; Litman T; Hohenberger P; Dietel M
Int J Cancer; 2002 Feb; 97(6):751-60. PubMed ID: 11857350
[TBL] [Abstract][Full Text] [Related]
7. Feasibility and safety of electrochemotherapy (ECT) in the pancreas: a pre-clinical investigation.
Girelli R; Prejanò S; Cataldo I; Corbo V; Martini L; Scarpa A; Claudio B
Radiol Oncol; 2015 Jun; 49(2):147-54. PubMed ID: 26029026
[TBL] [Abstract][Full Text] [Related]
8. (-)-Epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line.
Farabegoli F; Papi A; Bartolini G; Ostan R; Orlandi M
Phytomedicine; 2010 Apr; 17(5):356-62. PubMed ID: 20149610
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of P-glycoprotein functionality by vandetanib may reverse cancer cell resistance to doxorubicin.
Jovelet C; Bénard J; Forestier F; Farinotti R; Bidart JM; Gil S
Eur J Pharm Sci; 2012 Aug; 46(5):484-91. PubMed ID: 22484209
[TBL] [Abstract][Full Text] [Related]
10. (R)-[(11)C]verapamil is selectively transported by murine and human P-glycoprotein at the blood-brain barrier, and not by MRP1 and BCRP.
Römermann K; Wanek T; Bankstahl M; Bankstahl JP; Fedrowitz M; Müller M; Löscher W; Kuntner C; Langer O
Nucl Med Biol; 2013 Oct; 40(7):873-8. PubMed ID: 23845421
[TBL] [Abstract][Full Text] [Related]
11. Atorvastatin Modulates the Efficacy of Electroporation and Calcium Electrochemotherapy.
Szlasa W; Kiełbik A; Szewczyk A; Novickij V; Tarek M; Łapińska Z; Saczko J; Kulbacka J; Rembiałkowska N
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681903
[TBL] [Abstract][Full Text] [Related]
12. Effect of prostaglandin E2 on multidrug resistance transporters in human placental cells.
Mason CW; Lee GT; Dong Y; Zhou H; He L; Weiner CP
Drug Metab Dispos; 2014 Dec; 42(12):2077-86. PubMed ID: 25261564
[TBL] [Abstract][Full Text] [Related]
13. Characterisation of the brain multidrug resistance protein (BMDP/ABCG2/BCRP) expressed at the blood-brain barrier.
Eisenblätter T; Hüwel S; Galla HJ
Brain Res; 2003 May; 971(2):221-31. PubMed ID: 12706238
[TBL] [Abstract][Full Text] [Related]
14. Poncirin downregulates ATP-binding cassette transporters to enhance cisplatin sensitivity in cisplatin-resistant osteosarcoma cells.
Zhao L; Zhang W; Zhang F
Phytother Res; 2021 Jan; 35(1):278-288. PubMed ID: 32779800
[TBL] [Abstract][Full Text] [Related]
15. Establishment and biological analysis of the EC109/CDDP multidrug-resistant esophageal squamous cell carcinoma cell line.
Wen J; Zheng B; Hu Y; Zhang X; Yang H; Luo KJ; Zhang X; Li YF; Fu JH
Oncol Rep; 2009 Jul; 22(1):65-71. PubMed ID: 19513506
[TBL] [Abstract][Full Text] [Related]
16. Effects of Cisplatin Electrochemotherapy on Human Neuroblastoma Cells.
Esmekaya MA; Kayhan H; Coskun A; Canseven AG
J Membr Biol; 2016 Oct; 249(5):601-610. PubMed ID: 27021229
[TBL] [Abstract][Full Text] [Related]
17. ABC transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) expression in the developing human CNS.
Daood M; Tsai C; Ahdab-Barmada M; Watchko JF
Neuropediatrics; 2008 Aug; 39(4):211-8. PubMed ID: 19165709
[TBL] [Abstract][Full Text] [Related]
18. P-glycoprotein and breast cancer resistance protein in acute myeloid leukaemia cells treated with the aurora-B kinase inhibitor barasertib-hQPA.
Grundy M; Seedhouse C; Russell NH; Pallis M
BMC Cancer; 2011 Jun; 11():254. PubMed ID: 21679421
[TBL] [Abstract][Full Text] [Related]
19. [Correlation of chemosensitivity tested using histoculture drug response assay to expression of multidrug resistance genes and proteins in colorectal cancer tissues].
Yuan SQ; Zhou ZW; Liang YJ; Fu LW; Chen G; Qiu HB; Zhang LY
Ai Zheng; 2009 Sep; 28(9):932-8. PubMed ID: 19728910
[TBL] [Abstract][Full Text] [Related]
20. The use of high-frequency short bipolar pulses in cisplatin electrochemotherapy in vitro.
Scuderi M; Rebersek M; Miklavcic D; Dermol-Cerne J
Radiol Oncol; 2019 Jun; 53(2):194-205. PubMed ID: 31194692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
